The case revolves around the drug Rapamune ... U.S. Attorney Sanford Coats, in a statement. Pfizer has stressed that this off-label marketing occurred before it acquired Wyeth.

New York–based drug giant Pfizer is paying $2.3 billion to settle claims of off-label promotion of four of its drugs, including the cyclooxygenase 2 (COX-2) inhibitor Bextra (valdecoxib), the US ...

The US Food and Drug Administration (FDA ... according to ClinicalTrials.gov. "FDA expands Pfizer’s RSV vaccine label to ...

The Pfizer laboratories Friday announced the development of an experimental pill to treat COVID-19, which the pharmaceutical company claims cuts down the risk of hospitalization and death by 89% ...

Pfizer's fourth quarter beat expectations on strong sales of its Covid vaccine and pill, bolstering its sales as it seeks to fend off criticism from an activist investor that has argued the ...

WASHINGTON--Pfizer said Tuesday that its experimental pill to treat COVID-19 appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed ...

Searching for a weight-loss drug but don't like the idea of an injection? Pfizer may soon be able to help. The pharmaceutical company announced Thursday it's advancing development of its GLP-1 ...